Bank of America (BAC) Up 1.5% Since Last Earnings Report: Can It Continue?

Bank of America (BAC) reported Q2 2025 earnings of $0.89 per share, surpassing consensus estimates, primarily driven by robust trading revenue growth of 14.9% year-over-year and a 6.9% increase in net interest income (NII). However, investment banking fees remained subdued, declining 8.1%, while non-interest expenses rose 5.4%, leading to an increased efficiency ratio. Management projects NII to grow 6-7% for the full year 2025, anticipating expense growth to flatten in the second half, which is expected to improve operating leverage and efficiency over time.

Analysis

Bank of America's Q2 2025 results present a mixed operational picture, characterized by an earnings per share beat ($0.89 vs. $0.86 estimate) but a slight revenue miss. The primary drivers of performance were a robust 14.9% year-over-year increase in sales and trading revenue, marking the 13th consecutive quarter of growth in that segment, and a 6.9% rise in Net Interest Income (NII). These strengths, however, were offset by continued weakness in the investment banking division, where fees declined 8.1%, and by rising operational costs. Non-interest expenses climbed 5.4% year-over-year, causing the efficiency ratio to deteriorate to 64.93% from 64.26% in the prior-year quarter. While credit quality appears stable with unchanged non-performing loan levels, provisions for credit losses did increase by 5.6%. Management's forward guidance is constructive, projecting full-year NII growth of 6-7% and flattish expense growth in the second half of 2025, which, if achieved, would improve operating leverage. Despite these positive projections and a $5.3 billion share repurchase, the stock's 1.5% gain since the report has underperformed the S&P 500, reflecting investor caution over the mixed results and cost pressures.

Key Decisions for Investors

• Investors should closely monitor management's ability to deliver on its guidance for flattish expense growth in the second half of 2025, as this is the primary catalyst for improving the firm's efficiency ratio and operating leverage.
• A position in the stock requires weighing the sustained, strong performance in the trading division against the persistent 8.1% decline in investment banking fees, recognizing the divergence in segmental performance.
• Given the stock's recent underperformance against the S&P 500 and its neutral 'Hold' rating from Zacks, a cautious stance may be prudent until tangible evidence of margin improvement or a recovery in the investment banking cycle materializes.